Promoter polymorphism of IL-10 and severity of multiple sclerosis (Q54743167)

3 June 2018

title

Promoter polymorphism of IL-10 and severity of multiple sclerosis (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-0404.2003.00165.X

1 April 2024

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616291

1 April 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0404.2003.00165.X

1 April 2024

author name string

M. Luomala

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616291

1 April 2024

H. Huhtala

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616291

1 April 2024

M. Ukkonen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616291

1 April 2024

T. Koivula

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616291

1 April 2024

I. Elovaara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616291

1 April 2024

language of work or name

English

0 references

publication date

1 December 2003

1 reference

3 June 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0404.2003.00165.x

1 reference

https://api.crossref.org/works/10.1034/J.1600-0404.2003.00165.X

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0404.2003.00165.x/fullpdf

1 April 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0404.2003.00165.X

Acta Neurologica Scandinavica

1 April 2024

published in

1 reference

3 June 2018

volume

108

1 reference

3 June 2018

issue

6

1 reference

3 June 2018

page(s)

396-400

1 reference

3 June 2018

Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna.

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

An investigation of polymorphism in the interleukin-10 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

The CCR5 deletion mutation fails to protect against multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

The CTLA-4 gene is associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Genetic influence on cytokine production and fatal meningococcal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Interleukin-10: biology, role in inflammation and autoimmunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00165.X

7 January 2021

Interleukin-10 and its receptor

12

1 reference

https://api.crossref.org/works/10.1034/J.1600-0404.2003.00165.X

Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression

1 April 2024

22

1 reference

https://api.crossref.org/works/10.1034/J.1600-0404.2003.00165.X

1 April 2024

Identifiers

1 reference

3 June 2018

1 reference

3 June 2018